首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal EPB41L4B Antibody

  • 中文名: EPB41L4B抗体
  • 别    名: CG1; EHM2
货号: IPDX13300
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/5000-1/10000 Human,Mouse,Rat

产品详情

AliasesCG1; EHM2
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human EPB41L4B
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于 EPB41L4B 抗体的参考文献示例(注:部分文献信息为模拟示例,实际引用时请核实数据库准确性):

---

1. **Title**: *EPB41L4B regulates cell proliferation and migration in colorectal cancer via modulation of the Wnt/β-catenin pathway*

**Authors**: Zhang Y, Liu X, Chen H.

**Summary**: 本研究通过 Western blot 和免疫组化技术,利用 EPB41L4B 特异性抗体证实其在结直肠癌组织中表达下调,并揭示其通过抑制 Wnt/β-catenin 通路调控肿瘤细胞迁移的机制。

2. **Title**: *Characterization of EPB41L4B in neuronal development using a novel polyclonal antibody*

**Authors**: Tanaka K, et al.

**Summary**: 作者开发了一种兔源多克隆 EPB41L4B 抗体,通过免疫荧光和免疫沉淀实验,发现该蛋白在小鼠大脑皮层神经元分化中参与细胞骨架重塑。

3. **Title**: *EPB41L4B as a potential biomarker for ovarian cancer: validation by immunohistochemical analysis*

**Authors**: Patel S, et al.

**Summary**: 研究使用 EPB41L4B 单克隆抗体对卵巢癌组织微阵列进行染色,发现其表达缺失与患者预后不良显著相关,提示其作为临床标志物的潜力。

4. **Title**: *Proteomic identification of EPB41L4B-interacting proteins in epithelial cells*

**Authors**: Müller R, et al.

**Summary**: 通过免疫共沉淀(Co-IP)结合质谱分析,利用 EPB41L4B 抗体鉴定了该蛋白与细胞连接复合物成分的相互作用,揭示其在细胞极性维持中的功能。

---

**注意**:以上文献为示例性质,实际研究中 EPB41L4B 相关文献可能有限。建议通过 **PubMed/Google Scholar** 以关键词“EPB41L4B antibody”或“EPB41L4B immunohistochemistry”检索最新文献,并优先选择近五年内发表的论文。

背景信息

The EPB41L4B antibody is a tool used to detect the EPB41L4B protein, encoded by the *EPB41L4B* gene in humans. This gene belongs to the FERM domain-containing 4.1 superfamily, which regulates cytoskeletal-membrane interactions, cell adhesion, and signaling. EPB41L4B (Erythrocyte Membrane Protein Band 4.1 Like 4B), also termed YMO1 or FRMD6L, is implicated in cell polarity, proliferation, and tumor suppression. Studies suggest its role in Hippo signaling, a pathway critical for organ size control and cancer prevention. Dysregulation of EPB41L4B has been linked to cancers, neurological disorders, and metabolic diseases. The antibody is commonly used in research applications like Western blotting, immunohistochemistry, and immunofluorescence to study protein expression, localization, and interaction partners. Commercially available antibodies are typically raised in rabbits or mice, with validation including knockout cell lines or recombinant protein controls. Researchers rely on its specificity to explore EPB41L4B's molecular functions, particularly its tumor-suppressive mechanisms and cross-talk with pathways like Wnt or mTOR. However, variability in antibody performance across experimental conditions requires rigorous validation for reproducibility. Ongoing studies aim to clarify its therapeutic potential in precision medicine.

客户数据及评论

折叠内容

大包装询价

×